AnalystsKennen MacKayKennen MacKay's Stock Forecasts
AnalystsKennen MacKay
Analyst Ranking
Bottom 15%
#3930 out of 4565 analysts
Average Return
-3.32%
Win Rate
33%11 out of 33
Risk vs Reward
Poor
Good
Kennen MacKay's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Anaptysbio IncANAB | +410.11% | $23.73 | $121.05 | 2017-02-20 - 2018-02-21 | Buy |
Anaptysbio IncANAB | +194.20% | $32.07 | $94.35 | 2017-09-14 - 2018-04-04 | Buy |
Karyopharm Therapeutics IncKPTI | +70.18% | $11.00 | $18.72 | 2017-09-14 - 2018-09-14 | Buy |
Alexion Pharmaceuticals IncALXN | +54.27% | $99.39 | $153.33 | 2020-01-30 - 2021-01-29 | Buy |
Abeona Therapeutics IncABEO | +25.88% | $42.50 | $53.50 | 2020-03-17 - 2021-03-18 | Buy |
Kennen MacKay Analyst Color
Get additional color on Kennen MacKay's coverage of popular stocks
Kennen MacKay's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Nuvation Bio IncNUVB | 1 | Buy | $5.00 | +90.84% | Maintains | 9 days ago |
Agios Pharmaceuticals IncAGIO | 3 | Buy | $42.00 | +32.62% | Maintains | 10 months ago |
Amgen IncAMGN | 4 | Hold | $236.00 | N/A | Maintains | 2 years ago |
Immunogen IncIMGN | 1 | Hold | $6.00 | N/A | Downgrades | 2 years ago |
Arena Pharmaceuticals IncARNA | 1 | Hold | $100.00 | N/A | Downgrades | 2 years ago |
Exelixis IncEXEL | 2 | Buy | $31.00 | N/A | Maintains | 2 years ago |
Adc Therapeutics SaADCT | 2 | Buy | $34.00 | N/A | Maintains | 2 years ago |
Athenex IncATNXQ | 3 | Buy | $100.00 | N/A | Maintains | 3 years ago |
Atyr Pharma IncLIFE | 1 | Buy | $22.00 | N/A | Initiates Coverage On | 3 years ago |
Prothena Corp Public Ltd CoPRTA | 5 | Buy | $82.00 | N/A | Maintains | 3 years ago |
Seagen IncSGEN | 6 | Hold | $154.00 | N/A | Maintains | 3 years ago |
Acceleron Pharma IncXLRN | 2 | Hold | $179.00 | N/A | Maintains | 3 years ago |
Puma Biotechnology IncPBYI | 1 | Hold | $6.00 | N/A | Maintains | 3 years ago |
Biomarin Pharmaceutical IncBMRN | 4 | Hold | $88.00 | N/A | Maintains | 3 years ago |
Nurix Therapeutics IncNRIX | 1 | Buy | $42.00 | N/A | Initiates Coverage On | 3 years ago |
Mesoblast LtdMESO | 1 | Hold | $48.00 | N/A | Initiates Coverage On | 4 years ago |
Abeona Therapeutics IncABEO | 2 | Buy | $175.00 | N/A | Maintains | 4 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Buy | $135.00 | N/A | Reinstates | 4 years ago |
Merus NvMRUS | 3 | Buy | $23.00 | N/A | Upgrades | 5 years ago |
Obseva SaOBSVF | 3 | Buy | $24.00 | N/A | Initiates Coverage On | 6 years ago |
Anaptysbio IncANAB | 3 | Hold | N/A | N/A | Downgrades | 6 years ago |
Five Prime Therapeutics IncFPRX | 1 | Buy | $41.00 | N/A | Initiates Coverage On | 7 years ago |
Karyopharm Therapeutics IncKPTI | 1 | Buy | $14.00 | N/A | Initiates Coverage On | 7 years ago |
Ra Pharmaceuticals IncRARX | 1 | Buy | $21.00 | N/A | Initiates Coverage On | 7 years ago |
Bioverativ IncBIVV | 1 | Hold | $59.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.